| __timestamp | Agios Pharmaceuticals, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 176081000 |
| Thursday, January 1, 2015 | 141827000 | 157939000 |
| Friday, January 1, 2016 | 220163000 | 164073000 |
| Sunday, January 1, 2017 | 292681000 | 169243000 |
| Monday, January 1, 2018 | 1397000 | 168489000 |
| Tuesday, January 1, 2019 | 1317000 | 172526000 |
| Wednesday, January 1, 2020 | 2805000 | 200649000 |
| Friday, January 1, 2021 | 18777000 | 237513000 |
| Saturday, January 1, 2022 | 1704000 | 353358000 |
| Sunday, January 1, 2023 | 9504000 | 586886000 |
| Monday, January 1, 2024 | 4165000 |
In pursuit of knowledge
In the dynamic world of biotechnology, understanding cost structures is crucial for investors and stakeholders. This chart provides a fascinating comparison of the cost of revenue for Lantheus Holdings, Inc. and Agios Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Lantheus Holdings consistently outpaced Agios Pharmaceuticals in cost of revenue, peaking in 2023 with a staggering 587% increase from its 2014 figures. In contrast, Agios Pharmaceuticals experienced a more volatile trajectory, with a significant drop in 2018 and 2019, where costs plummeted by over 99% compared to 2017. This fluctuation highlights the challenges and unpredictability in the biotech sector. As Lantheus Holdings continues to expand its operations, its cost of revenue reflects a steady growth, while Agios Pharmaceuticals' figures suggest a strategic shift or restructuring during the mid-2010s.
Cost of Revenue Trends: Incyte Corporation vs Lantheus Holdings, Inc.
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Agios Pharmaceuticals, Inc.
Bio-Techne Corporation vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Lantheus Holdings, Inc.
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Agios Pharmaceuticals, Inc.
Lantheus Holdings, Inc. vs Perrigo Company plc: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
R&D Insights: How Lantheus Holdings, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Agios Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd.